The Current Ratio as of January 2025 (TTM) for Paradigm Biopharmaceuticals Limited (PAR.AX) is 7.22

According to Paradigm Biopharmaceuticals Limited’s latest financial reports and current stock price. The company's current Current Ratio is 7.22. This represents a change of 32.27% compared to the average of 5.46 of the last 4 quarters.

Paradigm Biopharmaceuticals Limited (PAR.AX) Historical Current Ratio (quarterly & annually)

How has PAR.AX Current Ratio performed in the past?

The mean historical Current Ratio of Paradigm Biopharmaceuticals Limited over the last ten years is 12.04. The current 7.22 Current Ratio has changed 5.90% with respect to the historical average. Over the past ten years (40 quarters), PAR.AX's Current Ratio was at its highest in in the December 2019 quarter at 66.64. The Current Ratio was at its lowest in in the January 2015 quarter at 0.

Paradigm Biopharmaceuticals Limited (PAR.AX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Paradigm Biopharmaceuticals Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Paradigm Biopharmaceuticals Limited (PAR.AX) Average Current Ratio

How has PAR.AX Current Ratio performed in the past?

The current Current Ratio of Paradigm Biopharmaceuticals Limited (PAR.AX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Paradigm Biopharmaceuticals Limited (PAR.AX) Current Ratio vs. Peers

How is PAR.AX’s Current Ratio compared to its peers?

Paradigm Biopharmaceuticals Limited’s Current Ratio is greater than PolyNovo Limited (3.41), less than AVITA Medical, Inc. (8.18), greater than Opthea Limited (2.94), greater than Mesoblast Limited (1.18), greater than Volpara Health Technologies Limited (0.95),

Build a custom stock screener for Paradigm Biopharmaceuticals Limited (PAR.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Paradigm Biopharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Paradigm Biopharmaceuticals Limited (PAR.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Paradigm Biopharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.